SS Innovations International (NASDAQ:SSII) Stock Price Down 8% - What's Next?

Key Points

• SS Innovations International's stock fell by 8% on Monday, dropping to a trading price of $6.23 with a significant decline in share volume of 91% compared to average daily trading.
• Large investors have recently increased their stakes in SS Innovations, with Forum Financial Management LP leading by acquiring a position worth about $344,000.
• The company, formerly known as AVRA Surgical Microsystems, focuses on developing medical surgical devices and is collaborating with the University of Central Florida in related research.

SS Innovations International, Inc. (NASDAQ:SSII - ) dropped 8% on Monday . The company traded as low as $6.20 and last traded at $6.23. Approximately 11,177 shares changed hands during mid-day trading, a decline of 91% from the average daily volume of 124,151 shares. The stock had previously closed at $6.77.

SS Innovations International Stock Down 4.0%

The stock has a fifty day moving average price of $5.88.

Hedge Funds Weigh In On SS Innovations International

Several large investors have recently bought and sold shares of the business. Forum Financial Management LP purchased a new position in shares of SS Innovations International during the second quarter worth about $344,000. Geode Capital Management LLC purchased a new position in shares of SS Innovations International during the second quarter worth about $122,000. Finally, AlTi Global Inc. purchased a new position in shares of SS Innovations International during the second quarter worth about $121,000.

SS Innovations International Company Profile

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.